# Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)

> **NCT02014363** · PHASE2 · COMPLETED · sponsor: **e-Therapeutics PLC** · enrollment: 164 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** ETS6103 (low dose)
- **DRUG:** ETS6103 (high dose)
- **DRUG:** Amitriptyline

## Key facts

- **NCT ID:** NCT02014363
- **Lead sponsor:** e-Therapeutics PLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02014363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02014363, "Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02014363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*